Inventor · disambiguated record
Veena Warikoo
Also filed as: WARIKOO VEENA
16 granted patents·7 pending applications·108 citations·filing 2013–2024
92Inventor score
Files withGENZYME CORP23
Top patents by PatentIndex Score
23 records- 0196US9657056B2Integrated continuous manufacturing of therapeutic protein drug substancesGENZYME CORP·Filed 2015·Granted May 23, 2017·22 cites·29 claims
- 0295US9650413B2Integrated continuous manufacturing of therapeutic protein drug substancesGENZYME CORP·Filed 2015·Granted May 16, 2017·22 cites·37 claims
- 0395US9650412B2Integrated continuous manufacturing of therapeutic protein drug substancesGENZYME CORP·Filed 2014·Granted May 16, 2017·34 cites·26 claims
- 0494US10711034B2Integrated continuous manufacturing of therapeutic protein drug substancesGENZYME CORP·Filed 2017·Granted Jul 14, 2020·7 cites·17 claims
- 0591US9630165B2Sterile chromatography resin and use thereof in manufacturing processesGENZYME CORP·Filed 2015·Granted Apr 25, 2017·6 cites·30 claims
- 0690US10071364B2Sterile affinity chromatography resinGENZYME CORP·Filed 2015·Granted Sep 11, 2018·7 cites·33 claims
- 0790US2024417427A1Integrated Continuous Manufacturing of Therapeutic Protein Drug SubstancesGENZYME CORP·Filed 2024·Application pending·0 cites
- 0889US10087214B2Sterile chromatography and manufacturing processesGENZYME CORP·Filed 2015·Granted Oct 2, 2018·6 cites·24 claims
- 0986US11839861B2Sterile chromatography resin and use thereof in manufacturing processesGENZYME CORP·Filed 2021·Granted Dec 12, 2023·1 cites·24 claims
- 1082US11912739B2Sterile chromatography and manufacturing processesGENZYME CORP·Filed 2020·Granted Feb 27, 2024·1 cites·20 claims
- 1182US11884703B2Methods of processing a fluid including a recombinant therapeutic protein and use thereofGENZYME CORP·Filed 2021·Granted Jan 30, 2024·1 cites·20 claims
- 1276US10920182B2Affinity-based analytical purification of biotherapeutics for bioprocess monitoringGENZYME CORP·Filed 2017·Granted Feb 16, 2021·1 cites·14 claims
- 1376US2024392030A1Methods of Controlling the Formation of Disulfide Bonds in Protein SolutionsGENZYME CORP·Filed 2024·Application pending·0 cites
- 1474US12110312B2Integrated continuous manufacturing of therapeutic protein drug substancesGENZYME CORP·Filed 2020·Granted Oct 8, 2024·0 cites·14 claims
- 1569US11203747B2Elution of biomolecules from multi-modal resins using MES and MOPS as mobile phase modifiersGENZYME CORP·Filed 2019·Granted Dec 21, 2021·0 cites·14 claims
- 1666US10919021B2Sterile chromatography resin and use thereof in manufacturing processesGENZYME CORP·Filed 2018·Granted Feb 16, 2021·0 cites·17 claims
- 1764US2018354986A1Sterile chromatography and manufacturing processesGENZYME CORP·Filed 2018·Application pending·0 cites
- 1858US2020299402A1Methods of Controlling the Formation of Disulfide Bonds in Protein SolutionsGENZYME CORP·Filed 2020·Application pending·0 cites
- 1956US10968252B2Methods of processing a fluid including a recombinant therapeutic protein and use thereofGENZYME CORP·Filed 2017·Granted Apr 6, 2021·0 cites·14 claims
- 2056US2014322699A1Affinity-Based Analytical Purification Of Biotherapeutics For Bioprocess MonitoringGENZYME CORP·Filed 2014·Application pending·0 cites
- 2155US2015203532A1Sterile chromatography and manufacturing processesGENZYME CORP·Filed 2015·Application pending·0 cites
- 2255US2015275195A1Elution of biomolecules from multi-modal resins using mes and mops as mobile phase modifiersGENZYME CORP·Filed 2013·Application pending·0 cites
- 2352US10647777B2Methods of controlling the formation of disulfide bonds in protein solutionsGENZYME CORP·Filed 2015·Granted May 12, 2020·0 cites·31 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →